Objective: Although psychological problems, such as anxiety and depression, can affect the quality of sleep, there is scant research on the link between decreased sleep quality and mental health in coronary artery disease (CAD) patients. This study aimed to explore the quality of sleep in CAD patients with and without abnormal anxiety and depressive complaints.
Methods And Results: In a cross-sectional setting, 163 CAD patients were consecutively selected. Using Hospital Anxiety Depression Scale (HADS), patients were divided into the following 4 groups: I(anx) (subjects with abnormal anxiety symptoms, n = 34), II(anx) (subjects without abnormal anxiety symptoms, n = 129), I(dep) (subjects with abnormal depressive symptoms, n = 34), and II(dep) (subjects without abnormal depressive symptoms, n = 129). Subsequently, sleep quality was compared between the study groups by means of Pittsburgh Sleep Quality Index were significantly (PSQI). Mean values of total PSQI score, subjective sleep quality, sleep latency and sleep disturbances in group I(anx) were significantly poorer than those in group II(anx). Also, mean values of total PSQI score and daytime dysfunction in group I(dep) were significantly poorer than those in group II(dep).
Conclusions: This study shows that there is a significant association between decreased quality of sleep and abnormal anxiety and depressive symptoms in CAD patients. Thus, we recommend that physicians check for the presence of the other related symptom when encountering patients with one of these complaints.
Download full-text PDF |
Source |
---|
Cancer Causes Control
December 2024
Department of Clinical Nutrition, the First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, 230022, Anhui, China.
Breast cancer is the leading cause of cancer-related death and the most common cancer among women worldwide. It is crucial to identify potentially modifiable risk factors to intervene and prevent breast cancer effectively. Sleep factors have emerged as a potentially novel risk factor for female breast cancer.
View Article and Find Full Text PDFJ Addict Dis
December 2024
Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.
No FDA-approved medications for methamphetamine (MA) use disorder (MUD) are available. Suvorexant (SUVO), a dual orexin receptor antagonist that is FDA approved for insomnia treatment, reduces MA self-administration and MA-induced reinstatement responding in preclinical studies. SUVO may also reduce MA use by targeting substance use risk factors, including insomnia, stress, cue reactivity, and craving.
View Article and Find Full Text PDFPsychol Health Med
December 2024
School of Public Health, China Medical University, Shenyang, Liaoning, China.
This study assessed the relationships among cognitive risk, phone use behaviors, and sleep quality. We used a questionnaire, which included the Pittsburgh Sleep Quality Index (PSQI), mobile phone use behaviours, and questionnaires on mobile phone use cognitive risk to gather information from 1204 college students. T-test, chi-square test, and Wilcoxon signed rank test were applied to test differences in measurement data.
View Article and Find Full Text PDFZh Nevrol Psikhiatr Im S S Korsakova
December 2024
Republican Scientific and Practical Center of Neurology and Neurosurgery, Minsk, Belarus.
Objective: To analyze the results of nocturnal breathing parameters during sleep based on nocturnal pulse oximetry and to study of characteristics of external respiration in genetically confirmed patients with dystrophic myotonia (DM).
Material And Methods: The subjects of the study were patients with genetically confirmed DM types 1 and 2 who were hospitalized in the neurological departments of the Republican Scientific and Practical Center for Neurology and Neurosurgery. The clinical picture of the disease, comorbidities, sleep questionnaires, laboratory tests, overnight pulse oximetry and spirometry were performed and analyzed.
Zh Nevrol Psikhiatr Im S S Korsakova
December 2024
Yaroslavl State Medical University, Yaroslavl, Russia.
Objective: To analyze the subjective sleep assessment in patients with neuromyelitis optica spectrum diseases (NMOSD) according to the current disease criteria of 2015.
Material And Methods: Twenty patients (17 women and 3 men), median age 44.5 years [Q:Q=27.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!